Canon Medical’s Digital PET/CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology
Retrieved on:
Thursday, June 10, 2021
Cardiology, Biotechnology, Practice Management, Technology, FDA, Health, Radiology, Oncology, Medical devices, Software, Hospitals, Medical physics, Medical imaging, Medicine, Neuroimaging, Radiology, Canon Inc., Companies, PET-CT, Applied sciences, Magnetic resonance imaging, Draft:Douglas P. Boyd, Canon Medical Systems USA, Inc., Canon Medical Systems Corporation, CANON MEDICAL SYSTEMS USA, INC., CANON MEDICAL SYSTEMS CORPORATION
An innovative approach to reconstruction, AiCE on the Cartesion Prime Digital PET/CT can provide fast exams at a lower dose with better image quality than traditionally acquired during both the PET and CT acquisitions.
Key Points:
- An innovative approach to reconstruction, AiCE on the Cartesion Prime Digital PET/CT can provide fast exams at a lower dose with better image quality than traditionally acquired during both the PET and CT acquisitions.
- Were taking innovation in molecular imaging one step further than ever thought possible with the availability of DLR on a digital PET/CT system.
- About Canon Medical Systems USA, Inc.
Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. - At Canon Medical, we work hand in hand with our partners - our medical, academic and research community.